Tumour necrosis factor alpha promoter polymorphism, TNF-238 is associated with severe clinical outcome of falciparum malaria in Ibadan southwest Nigeria

Autor: Olaniyan, SA, Amodu, OK, Bakare, AA, Troye-Blomberg, M, Omotade, OO, Rockett, KA, Consortium, Malariagen

Publikováno v: Acta Tropica. 161:62-67

Tumour necrosis factor (TNF) – α has been shown to play an important role in the pathogenesis of falciparum malaria. Two TNF promoter polymorphisms, TNF-308 and TNF-238 have been associated with differential activity and production of TNF. In orde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ed88fed8523010990e7691371f3abc
https://doi.org/10.1016/j.actatropica.2016.05.006

Trends of human sex ratio at birth and twinning rate in Ibadan, south-western Nigeria

Autor: Bakare, AA, Elegbede, EO, Osowole, OI

Publikováno v: Zoologist (The); Vol 9 (2011); 47-56

The human sex ratio at birth (SRB) and frequency of twinning are demographic parameters that vary among populations. A retrospective study was carried out to investigate the trend of SRB, as well as twinning rate in Ibadan, Nigeria. Data on sexes of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::0bb341fd0e5d07499c1cc44a3d5c4ca2
https://www.ajol.info/index.php/tzool/article/view/73128

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of a participatory whole-systems approach on mortality in children younger than 5 years in Jigawa state, Nigeria (INSPIRING trial): a community-based, parallel-arm, pragmatic, cluster randomised controlled trial and concurrent mixed-methods process evaluation.

Autor: King C; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Institute for Global Health, University College London, London, UK. Electronic address: carina.king@ki.se., Burgess RA; Institute for Global Health, University College London, London, UK., Bakare AA; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Shittu F; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria., Salako J; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria., Bakare D; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria., Uchendu OC; Department of Community Medicine, University College Hospital, Ibadan, Nigeria; Department of Community Medicine, University of Ibadan, Ibadan, Nigeria., Iuliano A; Institute for Global Health, University College London, London, UK., Djellouli N; Institute for Global Health, University College London, London, UK., Isah A; Save the Children International, Abuja, Nigeria., Haruna I; Save the Children International, Abuja, Nigeria., Ahmar S; Save the Children UK, London, UK., Ahmed T; Save the Children UK, London, UK., Valentine P; Save the Children UK, London, UK., Olowookere TF; GlaxoSmithKline, Lagos, Nigeria., MacCalla M; GlaxoSmithKline, Brentford, UK., Graham HR; Department of Paediatrics, University College Hospital, Ibadan, Nigeria; Centre for International Child Health, Murdoch Children's Research Institute, University of Melbourne, Royal Children's Hospital, Parkville, VIC, Australia., McCollum ED; Global Program in Pediatric Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Beard J; Guildford, UK., Falade AG; Department of Paediatrics, University College Hospital, Ibadan, Nigeria; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria., Colbourn T; Institute for Global Health, University College London, London, UK.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.